Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
Barden M, Elsenbroich PR, Haas V, Ertelt M, Pervan P, Velas L, Gergely B, Szöőr Á, Harrer DC, Bezler V, Holzinger A, Friis RUW, Vereb G, Schütz GJ, Schoeder CT, Hombach AA, Abken H.
Barden M, et al. Among authors: holzinger a.
J Immunother Cancer. 2024 Dec 2;12(12):e010208. doi: 10.1136/jitc-2024-010208.
J Immunother Cancer. 2024.
PMID: 39622582
Free PMC article.